Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02235623 · ClinicalTrials.gov registry record · NA
Orchidopexy Randomized Clinical Assessment
A NA study, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT02235623: Recruiting NA study, sponsored by Boston Children's Hospital.
NCT02235623 is a NA study that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02235623, a NA study, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
This is a randomized trial designed to evaluate testicular outcomes after a single stage versus a two-stage surgical procedure to fix an undescended, one-sided testicle located in the abdomen. Also to determine and compare the costs, surgical complications and the health related quality of life for the two procedures. Testicular outcomes will be measured using a scrotal ultrasound 6-12 months after the procedure (after the second stage procedure for those randomized to a 2 stage surgery).
Primary Outcome
To evaluate the volume of the operated testis at 6-12 months after single-stage Fowler-Stephens orchidopexy (FSO) (6-12 months after two- stage FSO), as determined by ultrasound measurements. This will be compared to the intra-operative testicular measurements done during the laparoscopy.
Interventions
- PROCEDURE Single-stage Fowler-Stephens orchidopexy (FSO)
- PROCEDURE Two-stage Fowler-Stephens orchidopexy (FSO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-08 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
What NCT02235623 shows while recruiting
NCT02235623 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Single-stage Fowler-Stephens orchidopexy (FSO) is the first listed.
NCT02235623 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02235623 about?
NCT02235623 is a clinical study titled "Orchidopexy Randomized Clinical Assessment". This is a randomized trial designed to evaluate testicular outcomes after a single stage versus a two-stage surgical procedure to fix an undescended, one-sided testicle located in the abdomen. Also to determine and compare the costs, surgical complications and the health related quality of life for ...
What is the current status of trial NCT02235623?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2014-08. Estimated completion is 2030-12-31.
What interventions are being tested in trial NCT02235623?
The interventions under investigation include: Single-stage Fowler-Stephens orchidopexy (FSO) (PROCEDURE), Two-stage Fowler-Stephens orchidopexy (FSO) (PROCEDURE).
Who is sponsoring clinical trial NCT02235623?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02235623's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia